Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan

por Iwata, Nakao, Inagaki, Ataru, Sano, Hiromi, Niidome, Kazunari, Kojima, Yoshitsugu, Yamada, Sakiko
Publicado 2020

Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study

por Ishigooka, Jun, Inada, Ken, Niidome, Kazunari, Aoki, Kazuo, Kojima, Yoshitsugu, Iwashita, Shuichi, Yamada, Sakiko
Publicado 2021